ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 135 filers reported holding ARCUS BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 4.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $593,000 | +259.4% | 17,000 | -15.0% | 7.18% | +175.8% |
Q2 2021 | $165,000 | -41.3% | 20,000 | +100.0% | 2.60% | -42.7% |
Q1 2021 | $281,000 | -90.5% | 10,000 | -94.2% | 4.54% | +61.7% |
Q3 2020 | $2,948,000 | -4.2% | 171,982 | +38.2% | 2.81% | -16.8% |
Q2 2020 | $3,078,000 | – | 124,404 | – | 3.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |